245 related articles for article (PubMed ID: 31073812)
1. Therapeutic Antibodies for Nasal Polyposis Treatment: Where Are We Headed?
Agarwal A; Spath D; Sherris DA; Kita H; Ponikau JU
Clin Rev Allergy Immunol; 2020 Oct; 59(2):141-149. PubMed ID: 31073812
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis-based application of biologics for chronic rhinosinusitis: Current and future perspectives.
Okano M; Kanai K; Oka A
Auris Nasus Larynx; 2024 Apr; 51(2):371-378. PubMed ID: 37743131
[TBL] [Abstract][Full Text] [Related]
3. Improvement in Smell Using Monoclonal Antibodies Among Patients With Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review.
Barroso B; Valverde-Monge M; Betancor D; Gómez-López A; Villalobos-Vilda C; González-Cano B; Sastre J
J Investig Allergol Clin Immunol; 2023 Dec; 33(6):419-430. PubMed ID: 37669083
[TBL] [Abstract][Full Text] [Related]
4. Dupilumab in chronic rhinosinusitis with nasal polyposis: current status, challenges, and future perspectives.
Li T; Yin J; Yang Y; Wang G; Zhang Y; Song X
Expert Rev Clin Immunol; 2023; 19(8):939-948. PubMed ID: 37378551
[TBL] [Abstract][Full Text] [Related]
5. Current and Novel Biologic Therapies for Patients with Asthma and Nasal Polyps.
Mandl HK; Miller JE; Beswick DM
Otolaryngol Clin North Am; 2024 Apr; 57(2):225-242. PubMed ID: 37684154
[TBL] [Abstract][Full Text] [Related]
6. Real-Life Effects of Omalizumab on Chronic Rhinosinusitis with Nasal Polyposis.
Lombardo N; Piazzetta GL; Lobello N; Cicala G; Patafi M; Benincasa AT; Pelaia C; Chiarella E; Pelaia G
J Pers Med; 2023 Dec; 14(1):. PubMed ID: 38276218
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic features of biologic therapy nonresponders in chronic rhinosinusitis with nasal polyposis.
Baird AM; Masliah J; Filip P; Talati V; Brown HJ; Owen G; Khalife S; Papagiannopoulos P; Gattuso P; Batra PS; Tajudeen BA
Int Forum Allergy Rhinol; 2024 May; 14(5):939-949. PubMed ID: 37792287
[TBL] [Abstract][Full Text] [Related]
8. Chronic Rhinosinusitis With Nasal Polyposis Treated With Dupilumab: Real-World Use and Outcomes.
Schmale IL; Poulakis A; Abend A; Luitje ME; Man LX
J Allergy Clin Immunol Pract; 2023 Oct; 11(10):3203-3210. PubMed ID: 37543087
[TBL] [Abstract][Full Text] [Related]
9. Adherence to Intranasal Steroids in Chronic Rhinosinusitis with Nasal Polyposis Prior to and during Biologic Therapy: A Neglected Matter.
Norelli F; Schiappoli M; Senna G; Pinter P; Olivieri B; Ottaviano G; De Corso E; Caminati M
J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398379
[TBL] [Abstract][Full Text] [Related]
10. Biologic Therapy in Pediatric Chronic Rhinosinusitis: A Systematic Review.
Rahavi-Ezabadi S; Zhou S; Lee SE; Ference E; Magit A; Leuin S; Mohamed K; Rezaei N; Patel VA
Otolaryngol Head Neck Surg; 2024 Mar; ():. PubMed ID: 38488239
[TBL] [Abstract][Full Text] [Related]
11. Biologics Reduce Symptoms of Alcohol Intolerance Better than Aspirin Desensitization in Patients with N-ERD and Nasal Polyps.
Foerster-Ruhrmann U; Jurkov M; Szczepek AJ; Bergmann KC; Fluhr JW; Olze H
Biomedicines; 2024 May; 12(5):. PubMed ID: 38790987
[TBL] [Abstract][Full Text] [Related]
12. Targeting IL-4 and IL-13 Receptors on Eosinophils in CRSwNP Patients: The Clinical Efficacy of Dupilumab.
Piazzetta GL; Lobello N; Chiarella E; Rizzuti A; Pelaia C; Pelaia G; Lombardo N
J Pers Med; 2023 Sep; 13(9):. PubMed ID: 37763171
[TBL] [Abstract][Full Text] [Related]
13. Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan.
Lombardi C; Comberiati P; Ridolo E; Cottini M; Yacoub MR; Casagrande S; Riccò M; Bottazzoli M; Berti A
Drugs; 2024 Jun; ():. PubMed ID: 38849701
[TBL] [Abstract][Full Text] [Related]
14. [Does aspirin therapy after desensitization still have a role in treatment of chronic rhinosinusitis with nasal polyposis in the era of biologics?].
Klimek F; Förster-Ruhrmann U; Hagemann J; Cuevas M; Gröger M; Klimek L
HNO; 2024 Feb; ():. PubMed ID: 38409556
[TBL] [Abstract][Full Text] [Related]
15. Multidimensional Impact of Dupilumab on Chronic Rhinosinusitis with Nasal Polyps: A Complete Health Technology Assessment of Clinical, Economic, and Non-Clinical Domains.
La Mantia I; Ottaviano G; Ragusa M; Trimarchi M; Foglia E; Schettini F; Bellavia D; Cantone E
J Pers Med; 2024 Mar; 14(4):. PubMed ID: 38672974
[TBL] [Abstract][Full Text] [Related]
16. The Inflation Reduction Act: Implications for Medicare spending and access to biologic therapies for chronic rhinosinusitis with nasal polyposis and asthma.
Rathi VK; Soler ZM; Schlosser RJ; Workman AD; Chapurin N; Rowan NR; Dusetzina SB
Int Forum Allergy Rhinol; 2024 Mar; ():. PubMed ID: 38465800
[TBL] [Abstract][Full Text] [Related]
17. Monitoring mepolizumab treatment in chronic rhinosinusitis with nasal polyps (CRSwNP): Discontinue, change, continue therapy?
Klimek L; Förster-Ruhrmann U; Olze H; Beule AG; Chaker AM; Hagemann J; Huppertz T; Hoffmann TK; Dazert S; Deitmer T; Strieth S; Wrede H; Schlenter WW; Welkoborsky HJ; Wollenberg B; Becker S; Bärhold F; Klimek F; Casper I; Zuberbier J; Rudack C; Cuevas M; Hintschich CA; Guntinas-Lichius O; Stöver T; Bergmann C; Werminghaus P; Pfaar O; Gosepath J; Gröger M; Beutner C; Laudien M; Weber RK; Hildebrand T; Hoffmann AS; Bachert C
Allergol Select; 2024; 8():26-39. PubMed ID: 38549814
[TBL] [Abstract][Full Text] [Related]
18. Nasal Polyposis: Insights in Epithelial-Mesenchymal Transition and Differentiation of Polyp Mesenchymal Stem Cells.
Chiarella E; Lombardo N; Lobello N; Aloisio A; Aragona T; Pelaia C; Scicchitano S; Bond HM; Mesuraca M
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961745
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of biologics for the treatment of chronic rhinosinusitis with nasal polyps in Canada.
Yong M; Kirubalingam K; Desrosiers MY; Kilty SJ; Thamboo A
Allergy Asthma Clin Immunol; 2023 Oct; 19(1):90. PubMed ID: 37838713
[TBL] [Abstract][Full Text] [Related]
20. Biologic Therapies in Chronic Rhinosinusitis with Nasal Polyposis: Overview of Systematic Reviews and Updated Systematic Review.
Mirza AA; Abdulazeem HM; Al-Sayed AA; Alandejani TA; Shawli HY; Thompson JY; Alhaddad MH; Varshney R; Zawawi F
Indian J Otolaryngol Head Neck Surg; 2023 Apr; 75(Suppl 1):650-660. PubMed ID: 37206723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
